Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3140290, 9 pages
http://dx.doi.org/10.1155/2016/3140290
Research Article

Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF-κB

1Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang 212001, China
2Faculty of Medicine, Changchun Medical College, Changchun 130013, China

Received 17 November 2015; Accepted 6 April 2016

Academic Editor: Andrea Vecchione

Copyright © 2016 Mingzhao Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. A. Sheikh, L. Pari, A. Rathinam, and R. Chandramohan, “Trans-anethole, a terpenoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats,” Biochimie, vol. 112, pp. 57–65, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Kerner and J. Brückel, “Definition, classification and diagnosis of diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 122, no. 7, pp. 384–386, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Winkler, T. Hidvegi, G. Vandorfi et al., “Risk-stratified screening for type 2 diabetes in adult subjects: results from Hungary,” Diabetologia, vol. 54, p. S119, 2011. View at Google Scholar
  4. Y. Pan, Y. Huang, Z. Wang et al., “Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy,” Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 231–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. N. M. Elsherbiny, M. El-Sherbiny, and E. Said, “Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib,” Journal of Physiology and Biochemistry, vol. 71, no. 4, pp. 635–648, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Q. Wu, T. R. Kosten, and X. Y. Zhang, “Free radicals, antioxidant defense systems, and schizophrenia,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 46, pp. 200–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Yaghobian, A. S. Don, S. Yaghobian, X. Chen, C. A. Pollock, and S. Saad, “Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy,” Clinical and Experimental Pharmacology and Physiology, vol. 43, no. 1, pp. 56–66, 2016. View at Publisher · View at Google Scholar
  8. D. S. Kania, J. D. Gonzalvo, and Z. A. Weber, “Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus,” Clinical Therapeutics, vol. 33, no. 8, pp. 1005–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Scheen, “Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?” Diabetes & Metabolism, vol. 33, no. 1, pp. 3–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Salihu Shinkafi, L. Bello, S. Wara Hassan, and S. Ali, “An ethnobotanical survey of antidiabetic plants used by Hausa-Fulani tribes in Sokoto, Northwest Nigeria,” Journal of Ethnopharmacology, vol. 172, pp. 91–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Pang, X.-T. Yu, Q. Zhou et al., “Effect of Rhizoma coptidis (Huang Lian) on treating diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 921416, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Yin, Y. Y. Liu, T. X. Wang et al., “Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model,” Psychopharmacology, vol. 233, no. 2, pp. 281–293, 2016. View at Publisher · View at Google Scholar
  13. S. Zareisedehizadeh, C.-H. Tan, and H.-L. Koh, “A review of botanical characteristics, traditional usage, chemical components, pharmacological activities, and safety of Pereskia bleo (Kunth) DC,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 326107, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Gao, M. Liu, J. Cao et al., “Protective effects of lycium barbarum polysaccharide on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway,” Molecules, vol. 20, no. 1, pp. 293–308, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Chen, L. Liang, Y. Wang et al., “Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo,” Molecular Medicine Reports, vol. 12, no. 5, pp. 6727–6737, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Cai, F. Liu, P. Zuo et al., “Practical application of antidiabetic efficacy of Lycium barbarum polysaccharide in patients with type 2 diabetes,” Medicinal Chemistry, vol. 11, no. 4, pp. 383–390, 2015. View at Publisher · View at Google Scholar
  17. H.-L. Tang, C. Chen, S.-K. Wang, and G.-J. Sun, “Biochemical analysis and hypoglycemic activity of a polysaccharide isolated from the fruit of Lycium barbarum L,” International Journal of Biological Macromolecules, vol. 77, pp. 235–242, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Dong, T. Jing, Q. Meng et al., “Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocin-induced diabetic sprague-dawley rats,” BioMed Research International, vol. 2014, Article ID 160980, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Rubattu, B. Pagliaro, G. Pierelli et al., “Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 823–839, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. E. Williams, “Diabetic nephropathy: the proteinuria hypothesis,” American Journal of Nephrology, vol. 25, no. 2, pp. 77–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yki-Jarvinen, “Glucose toxicity,” Endocrine Reviews, vol. 13, no. 3, pp. 415–431, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Tang, H. Gao, S. Wang, S. Wen, and S. Qin, “Hypolipidemic and antioxidant properties of a polysaccharide fraction from Enteromorpha prolifera,” International Journal of Biological Macromolecules, vol. 58, pp. 186–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-T. Huang, D. Leu, and Y. Zou, “Oxidative stress and redox regulation on hippocampal-dependent cognitive functions,” Archives of Biochemistry and Biophysics, vol. 576, pp. 2–7, 2015. View at Publisher · View at Google Scholar
  24. J.-H. Park, N. S. Park, S. M. Lee, and E. Park, “Effect of Dongchunghacho rice on blood glucose level, lipid profile, and antioxidant metabolism in streptozotocin-induced diabetic rats,” Food Science and Biotechnology, vol. 20, no. 4, pp. 933–940, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Sebai, S. Selmi, K. Rtibi, A. Souli, N. Gharbi, and M. Sakly, “Lavender (Lavandula stoechas L.) essential oils attenuate hyperglycemia and protect against oxidative stress in alloxan-induced diabetic rats,” Lipids in Health and Disease, vol. 12, article 189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Ceriello, A. Novials, E. Ortega et al., “Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes,” Diabetes Care, vol. 36, no. 12, pp. 4104–4108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Hua, H.-Z. Huang, L.-T. Tan et al., “CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress,” PLoS ONE, vol. 10, no. 5, Article ID e0127507, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. E. N. Ellis and B. H. Good, “Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus,” Metabolism, vol. 40, no. 10, pp. 1016–1019, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Boyman, A. G. Kolios, and M. E. Raeber, “Modulation of T cell responses by IL-2 and IL-2 complexes,” Clinical and Experimental Rheumatology, vol. 33, no. 4, supplement 92, pp. 54–57, 2015. View at Google Scholar
  30. R. Bertelli, A. Di Donato, M. Cioni et al., “LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity,” PLoS ONE, vol. 9, no. 10, Article ID e111285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Peters, W. Bloch, C. Wickenhauser et al., “Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in β2 integrin-deficient mice,” Journal of Leukocyte Biology, vol. 80, no. 3, pp. 599–607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Honkanen, E. Von Willebrand, A.-M. Teppo, T. Törnroth, and C. Grönhagen-Riska, “Adhesion molecules and urinary tumor necrosis factor-α in idiopathic membranous glomerulonephritis,” Kidney International, vol. 53, no. 4, pp. 909–917, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kosugi, T. Nakayama, M. Heinig et al., “Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice,” American Journal of Physiology—Renal Physiology, vol. 297, no. 2, pp. F481–F488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Pan, Y.-J. Wang, L. Han, X. Liu, M. Zhao, and Y.-F. Yuan, “Effects of sodium houttuyfonate on expression of NF-kappaB and MCP-1 in membranous glomerulonephritis,” Journal of Ethnopharmacology, vol. 131, no. 1, pp. 203–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Li, Y. Zhang, and J. Zhao, “Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats,” International Immunopharmacology, vol. 7, no. 1, pp. 23–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. W. O. Oh, Y.-M. Lee, S. Kim, H. J. U. Chin, D.-W. Chae, and K. Y. O. Na, “Cobalt chloride attenuates oxidative stress and inflammation through NF-κB inhibition in human renal proximal tubular epithelial cells,” Journal of Korean medical science, vol. 29, supplement 2, pp. S139–S145, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Song, Y. Wang, C. Liu et al., “Cordyceps militaris fruit body extract ameliorates membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the NF-κB pathway,” Food & Function, 2016. View at Publisher · View at Google Scholar
  39. S. R. Kolati, E. R. Kasala, L. N. Bodduluru et al., “BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway,” Environmental Toxicology and Pharmacology, vol. 39, no. 2, pp. 690–699, 2015. View at Publisher · View at Google Scholar · View at Scopus